Pediatrix Reports Q3 2026 Net Revenue of $501.4 Million
Pediatrix Medical Group reported net income of $47.0 million, or $0.59 per diluted share. Adjusted diluted EPS was $0.72, versus $0.67 a year earlier. It forecast 2026 Adjusted EBITDA of $290 million to $300 million.
Story updates
11:11:36 AM UTC
SquawkNews
Pediatrix Medical Group, Inc. reported third-quarter 2026 revenue of $501.4 million, up 1.7% year over year, while net income fell 34.4% to $47 million and diluted EPS declined to $0.59 from $0.84.Financial HighlightsBusiness HighlightsOriginal SEC Filing: Pediatrix Medical Group, Inc. [ MD ] - 10…
Pediatrix Medical Group reported third-quarter 2026 net revenue of $501.4 million and net income of $47.0 million, or $0.59 per diluted share. Adjusted diluted EPS was $0.72, compared with $0.67 in the prior-year quarter. The company forecast full-year 2026 Adjusted EBITDA of $290 million to $300 m…